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Discrete Choice Experiments with duration (DCETTO) can be used to estimate utility values for 
preference-based measures, such as the EQ-5D-5L. For self-completion, the health dimensions are 
presented in a standard order.  However, for valuation, this may result in order effects.  Thus, it is 
important to understand whether health state dimension ordering affects values. The aim of this study 
was to examine the importance of dimension ordering on DCE values using EQ-5D-5L. 
Methods: 
A choice experiment presenting two health profiles and a third immediate death option was 
developed. A three-arm study was used, with the same 120 choice sets presented online across each 
arm (n=360 per arm).  Arm 1 presented the standard EQ-5D-5L dimension order, Arm 2 randomised 
order between respondents, and Arm 3 randomised within respondents. Conditional logit regression 
was used to assess model consistency, and scale parameter testing was used to assess model 
poolability. 
Results: 
There were minor inconsistencies across each arm, but the magnitude of the coefficients produced 
were generally consistent. Arm 3 produced the largest range of utility values (1 to -0.980).  Scale 
parameter testing suggested that the models did not differ, and the data could be pooled.  Follow up 
questions did not suggest variation in terms of difficulty. 
Conclusions: 
The results suggest that the level of randomisation used in DCE health state valuation studies does 
not significantly impact values, and dimension order may not be as important as other study design 
issues.  The results support past valuation studies that use the standard order of dimensions.  
 




Key points for decision makers 
• The development of EQ-5D-5L value sets for use in the estimation of Quality Adjusted Life 
Years is influenced by many of the methodological choices made, potentially including the 
order in which the dimensions are presented 
• The results of this study suggest that values are similar across different three levels of 
dimension ordering (the ‘standard’ EQ-5D-5L order, and between and within respondent level 
randomisation) 
• Therefore using the standard EQ-5D-5L order is reasonable, and the results of past studies 
presenting this order can be used with confidence 
 
Introduction 
Economic evaluations of health care interventions often use the Quality Adjusted Life Year (QALY) as 
the outcome measure. The QALY is a single index metric combining length and quality of life.  The 
‘quality’ weight (or utility score) is commonly derived using a generic preference based measure 
(PBM) such as the EQ-5D [1] or SF-6D [2,3]. PBMs use a health state classification system and utility 
scores are assigned to the health states described, which are anchored on a 1 (full health) to 0 (dead) 
scale.   
 
Utility scores are derived using a preference elicitation task such as Time Trade Off (TTO; widely 
used for the EQ-5D [4]), Standard Gamble (SG; used for the SF-6D [2,3]) or Discrete Choice 
Experiments (DCE). DCEs require respondents to choose between two or more profiles described by 
the PBMs, and the resulting estimation of a model based on these choices produces values on a 
latent scale [5].  DCE including an attribute for duration (described as DCETTO [6]) allow the latent 
values to be anchored on the full health-dead utility scale.  The approach has gained popularity in 
recent years, and has been shown to generate models that are consistent with other valuation 
methods, and potentially reduce administrative burden on respondents, and also the cost of data 
collection,  Studies have been carried out online with general population samples for the three level 
EQ-5D (EQ-5D-3L) in Canada [6] and Australia [7], the five level EQ-5D (EQ-5D-5L) in Australia [8] 
and the UK [9,10] and the SF-6D in Australia [11].  
 
A potential methodological issue for the use of DCE, as well as other valuation methods, is the order 
in which the dimensions are presented to respondents.   In the majority of EQ-5D valuation studies, 
the dimensions are presented in the standard order seen by patients when self-completing the 
instrument (i.e. mobility (MO), self-care (SC), usual activities (UA), pain/discomfort (PD), and 
anxiety/depression (AD)). As well as consistency with the patient self-report version, for valuation it 
could be hypothesised that including the three functioning dimensions (MO-SC-UA) first allows 
respondents to generate a picture of aspects of health functioning before moving onto the more 
specific symptoms of PD and AD.  However while there is an inherent logic to this ordering, it is 
possible that the order in which dimensions are presented may also influence the overall perception of 
the health state and also the resulting values which could be influenced by task completion strategies. 
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For example in a number of studies [4,7], mobility has been the main driver of utility (i.e. modelled to 
have the overall largest decrement), which might partially reflect the position of that dimension in the 
valuation task. 
 
Recent work has started to investigate the impact of dimension order on the valuation of health states.  
Tsuchiya and colleagues [12] presented EQ-5D-5L health states in four different dimension orders in 
a DCE with duration (DCETTO) task online and found differences in the magnitude of the dimension 
coefficients across the different orders, although the impact was not systematic.  Mulhern and 
colleagues [13] tested TTO and DCE using face-to-face interviews and found some evidence that (for 
DCE) order impacted on the size of the coefficients reported, but again the pattern was unclear.  
Conversely, Norman and colleagues [14] found no impact of dimension order in a DCETTO study 
valuing a cancer specific preference based measure (EORTC QLU-C10D).  Outside of health state 
valuation, Kjaer and colleagues [15] found that the position of the price attribute in study investigating 
patient preferences for psoriasis treatment was important to price sensitivity.  
 
It is also worth noting that in testing for the impact of dimension order it is important to account for 
scale, which could be interpreted as choice consistency [16,17].  While there are several potential 
sources of scale heterogeneity, an intuitive one in this context is that ordering of the health state 
dimensions can impact respondents’ ability to engage with and complete the choice task, leading to 
differing error variance (and scale) across order presentations. Different ordering could therefore 
systematically impact: (a) preferences only; (b) scale only; (c) both preferences and scale.  The 
coefficients estimated from discrete choice models, often interpreted as preference parameters, are in 
fact confounded with scale.  As such, where past work has qualitatively shown that the magnitude of 
the coefficients does not differ across different dimension orders, it could be that preferences do in 
fact differ but this is masked by the scale confound.  Or conversely, where magnitudes of estimated 
preference parameters appear different, they may actually be the same after scale has been 
accounted for.  As such, appropriate tests are required to disentangle such effects.   
 
The ambiguous findings regarding the impact of dimension ordering on the valuation of a generic 
PBM such as EQ-5D-5L imply that it is important to test the issue systematically.  The aim of this 
study was to assess the impact of health state dimension ordering on DCETTO models with a 
representative sample of the Australian general population.  This develops the dimension order 
research into other valuation methods carried out elsewhere (with inconclusive results) to test DCETTO 
in a more systematic way using the generic EQ-5D-5L. DCETTO was used in this study as it is 
becoming more widely internationally, but various methodological issues including dimension order 
need to be tested to improve knowledge about the method.  Therefore this study will provide further 
information about the relatively new technique, and may inform the level of dimension randomisation 






The DCETTO choice sets used the EQ-5D-5L [18] which classifies health states across five dimensions 
(mobility, self-care, usual activities, pain/discomfort and anxiety/depression) with five levels of severity  
(none, slight, moderate, severe, extreme/unable to).  The DCETTO scenarios used in this study were 
based on methods used in previous studies [7,8,11] and consist of a choice between two EQ-5D-5L 
health states with associated duration (option A and option B) and also include a third option 
‘immediate death’, which is fixed as option C in each choice task. Duration always appeared at the 
bottom of the choice sets, as the focus of this study is the potential variation in the health state 
dimensions included in the EQ-5D-5L.  The four duration levels used were 2, 4, 8 and 16 years which 
were the same used in previous Australian EQ-5D DCETTO studies [7,8, 19].  Respondents were 
asked to choose the best and worst of the three options, providing a complete rank of the three 
options.  Figure 1 presents a screenshot of the task with the dimensions in the ‘standard’ order. 
 
Study design and state selection 
A three arm study design, with the same choice sets administered across each arm, was used.  Arm 1 
presented the ‘standard’ order (MO-SC-UA-PD-AD-Duration), and acted as the control arm.  Five 
items can be ordered a total of 120 possible ways, e.g. MO-SC-AD-PD-UA-Duration; SC-AD-PD-UA-
MO-Duration and so on.  Arm 2 randomised the 120 possible EQ-5D-5L orders between respondents, 
so that order differed across respondents but any individual respondent  saw the same order for all 
choice sets.  This randomisation method was included to allow each possible order to appear, whilst 
maintaining a similar level of difficulty for respondents as arm 1 given that only one order is seen.  
Arm 3 tested the impact of randomising the order within respondents, so each choice set had a 
different order that was randomly selected by the survey system, and was uncorrelated with the levels 
shown in each dimension of the choice set.  This arm was included to assess whether respondents 
could validly complete DCETTO tasks where the order changed each time.   
 
Comparing Arms 1 and 2, we might expect the first dimension that a respondent reads to be more 
important in determining their final choice than the middle ones.  Therefore, in our case, the 
importance of mobility in Arm 2 may be less than in Arm 1, and the first dimension a person sees may 
have a greater weight in Arm 2 for a given order than it has in Arm 1 (given that it appears first, and 
notwithstanding the impact of variability).  Arm 3 was expected to generate more inconsistent data 
and greater variability (in terms of both ordering and magnitude of the coefficients and also in terms of 
scale/error variance) in comparison to Arms 1 and 2 given the cognitive burden of having to complete 
choice tasks where the order changed each time.  We aimed to collect a sample of approximately 360 
respondents per arm to enable parameter estimation for each arm separately, and also for the pooled 
data, with approximately the same level of precision.   
 
To estimate DCETTO models, the number of choice sets included should exceed the number of 
parameters that are being estimated in the model. In this case, the maximum number of parameters 
for DCETTO of EQ-5D-5L including five dimensions, continuous duration, and coefficient for each 
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dimension order position would be 37 (the sum of: the interaction of duration and each of the EQ-5D-
5L main effects (5 dimensions x (5-1) levels x continuous duration (1) = 20); a linear duration term (1); 
the interaction of dimension order, position and level ((5-1) dimensions x (5-1) levels) = 16).  
Therefore including 120 choice sets in the design allowed for reliable parameter estimation and 
comparison across the arms. These were selected using a d-optimal procedure within the 
experimental design software NGene [20]. The same 120 choice sets were administered across each 
arm, with each respondent completing 10 choice sets that were randomly selected from the overall 
pool. This is in line with the choice set randomisation procedure carried out in DCETTO studies 
elsewhere [7,8] and gives approximately 90 observations per choice set (with approximately 30 per 
choice set per arm).  This is within the range used in other DCETTO studies [8,9] and justifies including 
approximately 360 respondents in each. 
 
 
Recruitment and data collection 
The survey was administered to an online panel (Pure Profile), representative of the Australian 
population in terms of age and gender.  Members of the online panel accessed an invitational weblink, 
and completed demographic and self-reported health questions, 10 DCETTO tasks, and then a series 
of follow-up questions assessing the difficulty of the choice tasks, difficulty in imagining the states, 
and whether they considered all or only part of the descriptions provided when answering.  The study 
was approved by the University of Technology Sydney Human Research Ethics Committee.  
 
Analysis 
Estimating and comparing individual models 
Conditional logit regression was used to generate unanchored and anchored estimates across the 
three arms using the model: 
𝑢𝑗 = 𝛽𝑡𝑗 + 𝝀
′𝒙𝑗𝑡𝑗 + 𝜀𝑗        (1) 
where β is the utility of living in full health for duration t, λ is the utility of living in state x for duration t, 
and ɛ is the error term. The coefficients for the interactions between health state dimension and 
duration are anchored to the utility scale by assuming that the utility of living in full health for a shorter 
duration is equal to living in a sub-optimal state for a longer duration.  This means that the anchored 
values for each level of each dimension are produced by dividing the interaction coefficients by the 
coefficient for duration (both estimated from the conditional logit regression displayed in equation 1) 
as shown in equation 2: 
𝑉𝑗 = 1 +
?̂?′
?̂?
𝒙𝑗          (2) 
 
Further information on the method can be found in Bansback et al [7].  In the analysis presented here, 
we model the choices between the two health state and duration combinations, and exclude the 
immediate death option data. This means that in the analysis reported here we use the respondent’s 
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choice of best and worst of the scenarios to rank all three of those presented in each choice set, and 
then assume IID to model the data from the two scenarios where the respondent will have provided 
an indication of which they think is best.  This approach to modelling similar data has been done 
elsewhere [7,8] and is repeated here as the focus of this paper is the scenarios where the dimension 
order is manipulated. Also, it has been shown that the way in which the ‘dead’ data is modelled 
affects the coefficient values [19]. Across the arms we compared the consistency of the dimension 
level coefficients (in terms of the amount of disordered levels, where the magnitude of an ordered 
coefficient increases as the severity level increases).  The characteristics of the EQ-5D-5L value sets 
were also compared. This included directly comparing the range of utility values and the overall 
magnitude of the dimension level coefficients (which controls for scale as all magnitudes are relative 
to the respective coefficient on duration). Comparing the magnitude of the coefficients across the 
arms in comparison to where they appear allows inferences about the impact of fixed and variable 
ordering 
 
Assessing differences between the arms 
We tested the null hypothesis that values do not differ across the three arms using a Swait and 
Louviere [14] test, which examines the variability between the systematic and random components of 
a DCE design.  If we fail to reject the null hypothesis the data can be pooled.  The test is carried out 
by using a grid search [17] to identify the relative scale parameters of the experimental Arms (2 and 
3), with the control Arm (1) normalised to one, that result in the maximum log likelihood for Arms 2 
and 3.  A restricted pooled model scaled using the parameters identified (Lµ) is estimated along with 
an unrestricted pooled (Lp) and individual models for each arm (L1, L2 and L3) using conditional logit.  
To assess differences, two likelihood ratio (LR) tests are used to compare the models (see equations 
3 and 4). If the LR statistic is within a critical value then the null hypothesis cannot be rejected and the 
data can be pooled and models estimated with no scale parameter adjustment. 
LR = -2[Lµ - (L1 + L2 + L3)]                (3) 
LR = -2(Lµ - Lp)                                 (4) 
 
Testing the impact of dimension order 
We modelled the impact of dimension order, where alongside the dimension parameter we estimated 
interactions between dimension position and severity level. This is because the effect of the 
dimension level which is expressed as a coefficient decrement (e.g. the disutility of poor mobility) 
cannot be separated from any dimension order effect (the focus on the first dimension) which is 
included within the decrement. If the first dimension is given particular attention, then the coefficients 
for mobility will be artificially inflated. By randomising the dimension order we were able to separately 
identify dimension effects (the coefficients for each level) from order effects (coefficients based on the 
order of appearance), as each of the arms included the same choice sets.   
 
The model to test dimension order was:  
𝑢𝑗 = 𝛽𝑡𝑗 + 𝝀
′𝒙𝑗𝑡𝑗 + 𝑃
′𝒙𝑗𝑡𝑗 + 𝜀𝑗              (5) 
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Where  λ’ is the marginal effect of dummies relating to interactions between duration (t) and 
movements away from level one in each of the five health state dimensions (x) (therefore 20 
coefficients).
'P is a dummy for the health state dimension appearing in order position 2, 3, 4 or 5 
which is interacted with the health state dimension severity level (x) and duration (t)(therefore16 
coefficients).  Dimension order effect parameters are not fitted to the dimension in the first position in 
the choice set) or to level 1 in each dimension to avoid over-specification. As an example of this, if we 
use a fixed ordering of dimensions, the coefficient for the MO2 and duration interaction also currently 
includes a coefficient for the effect of the first dimension being at level 2. By identifying this 
independently a value for the health state dimension without the effect of the dimension level and 
position can be obtained. These models were run using only responses from those who saw a non-
standard ordering of dimensions, so data from arm 1 was excluded.  To account for clustering of 
responses within respondents, we adjusted the standard errors using a clustered sandwich estimator, 
and then ran an F-test to explore the joint significance of the order effect terms. We also carried out 
descriptive analysis of the follow up questions across the arms, using chi squared tests. Analysis was 
carried out using Stata version 13 [21]. 
 
Results  
Response rate and demographics 
Overall, 2,710 respondents accessed the survey. Of these, 1,576 (58%) were classified as “over 
quota” (i.e. belonging to a particular age/gender quota group that had already been completed) so 
were excluded before completing the survey, 61 (2%) dropped out during completion, and 1,073 
(40%) fully completed the survey (Arm 1 n=366 (34%); Arm 2 n=346 (32%); Arm 3 n=361 (34%)). The 
mean time taken to complete was 11.7 minutes (range 2.3 mins to 63.4 mins), and this did not differ 
across the arms (p = 0.724).  
 
Table 1 reports the demographic characteristics and self-reported health status of the sample.  The 
sample is generally representative of the Australian general population in terms of age and gender, 
and there were no significant differences in any of the background characteristics across the arms. 
 
DCETTO models 
Table 2 reports the unanchored interaction coefficients (with the disordered coefficients bolded) and 
the value of the anchored coefficients for each arm (Figure 2 also presents the anchored values).  
Across all three arms, the majority of the modelled decrements are ordered as expected (17 of 20 for 
Arms 1/2, and 19 of 20 for Arm 3).  Regarding disordering, the coefficient for the usual activities 
dimension level 3 is smaller than level 2 meaning that ‘moderate’ problems results in a smaller 
decrement than ‘slight’ problems, but the difference between the levels is not significant.  Relative to 
Arm 3, Arms 1 and 2 each have an additional two disordered coefficients.  Arm 1 has evidence of 
small non-significant inconsistencies at level two of pain/discomfort and level five of 
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anxiety/depression.  Arm 2 has evidence of small non-significant inconsistencies at level five of usual 
activities and anxiety/depression.  In terms of dimension ‘importance’, Arms 1 and 3 have the same 
order (MO – SC – PD – AD – UA) and the order of the first three differs for Arm 2 (PD – MO – SC – 
AD – UA).  The range of utility values (i.e. the values assigned to 11111 and 55555) is smallest for the 
‘fixed’ order (Arm 1; 1 to -0.785) and increases for the between (Arm 2; 1 to -0.795) and within (Arm 3; 
1 to -0.980) randomisation levels.  
 
Hypothesis testing for preference and scale differences 
The scale parameters identified from the grid search following the methodology of Swait and Louviere 
[16] were 0.938 (Arm 2) and 0.998 (Arm 3).  The scale parameter of Arm 1 is fixed at 1. The 
difference between the Arm 1 fixed value and the Arm 2 scale parameter is larger than for Arm 3, and 
therefore Arm 2 has slightly more variability.  Table 3 displays the scaled restricted (Lµ, estimated 
using the scale parameters) and unrestricted (Lp) pooled models and the log likelihood statistics for 
these.  The log likelihood statistics for the three individual models (L1-L3) are reported in Table 2.  The 
results of the likelihood ratio tests indicate that the difference in the log likelihoods between the scaled 
and individual models (LR = 43), and scaled and unrestricted model (LR = 2) mean that the null 
hypothesis of no difference across the arms cannot be rejected and the data can be pooled. 
  
Testing the impact of dimension order 
The analysis with order effect terms estimated is reported in Table 4. Of the 16 additional coefficients 
estimated, only one was statistically significant at the 5% level, and the magnitude of the coefficients 
was small relative to the coefficients relating to specific EQ-5D dimension-level combinations. 
Running an F-test on the joint significance of the additional 16 order effect coefficients fails to reject 
the null hypothesis of no order effect (p=0.0606). 
 
Follow up questions about task difficulty and completion strategies 
Table 5 reports the results of follow up questions focusing on completion strategies across each arm.   
Overall, 632 respondents (58%) reported focusing on a particular part of the health description, 
although this did not differ across the arms (p=0.122). The pain dimension was focused on the most, 
and this did not vary across the arms. There were no differences in the consistency of the models 
produced across the arms (in terms of the coefficient decrements) based on whether the respondent 
reported focusing on all or part of the description. In total, 251 respondents (23%) reported using no 
strategy to complete the DCE, 452 (42%) reported only focusing on ‘few’ or ‘most’ aspects, and 370 
(34%) reported focusing on ‘all’ aspects, and the completion strategies reported did not differ across 
the arms. 
 
Figure 3 reports the results of the follow up questions focusing on task difficulty.  The majority of the 
respondents reported that the task was clear.  There was no difference across the arms in terms of 
respondents reporting that the task was difficult overall, in terms of telling the difference between the 
descriptions or in imagining the scenarios.  There was also no difference in the frequency of 
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respondents reporting that the order in which the dimensions were presented was confusing, where 
the majority agreed that the order was not confusing. 
 
Discussion 
This study tested the impact of different levels of EQ-5D-5L dimension order randomisation on the 
magnitude and consistency of the modelled health dimension coefficients using the DCETTO valuation 
method.  This included using the standard order of dimensions (used widely in other valuation 
studies), and two different levels of randomisation: one arm varied dimension order between subjects, 
and the other varied dimension order within subjects. The analysis found that the order of the 
magnitude of coefficients on levels within an attribute, while at times inconsistent, was similar across 
the arms.  Importantly, the non-significant differences in the modelled results across the arms suggest 
that the order in which the dimensions are presented does not have a major impact on the magnitude 
of the modelled coefficients or the overall dimensions when using a DCE with duration to value health 
states. The findings are in line with the results of Norman and colleagues [14] who found no impact of 
dimension order on the valuation of a cancer specific PBM (EORTC QLU-C10D) Therefore the 
evidence suggests that dimension order may not affect the values produced as much as other 
DCETTO study design issues.  These include the use of prior values in the design of the study [22], the 




We found small non-systematic differences across the arms. The results do not support the 
hypothesis that particular patterns of dimension orders may lead to particular patterns of modelled 
coefficients.  An example of a response pattern may be respondents focusing on the first or last 
dimensions presented whilst answering the task rather than comparing all of the dimensions. 
However there is the indication of differences in the overall range of the values and also the 
magnitude of the coefficients (and therefore utility decrements), and this may have implications if the 
values were used to estimate QALYs.  For example Arm 2 would place more weight on improvements 
in pain/discomfort.  The larger range of Arm 3 would lead to a relative emphasis on interventions that 
improve quality of life.  However it is unclear if these patterns would be the same using a larger 
sample as would be recruited to produce a nationally representative value set for use in cost utility 
analysis.  It is worth noting that the pooled sample coefficient order (MO-SC-PD-AD-UA) and range (1 
to -0.857) differs to that found in the earlier pilot valuation of EQ-5D-5L in Australia that used the 
standard order (where the magnitude of the coefficients was AD-PD-MO-SC-UA and range 1 to -
0.723 for the most comparable model) [8]. The findings from Arm 1 show that the first dimension 
presented (MO) had the largest decrement.  However this is difficult to interpret as mobility is also 
largest for Arm 3, but only appears first approximately 20% of the time meaning that the importance of 
mobility may be an indication of genuine preferences. It would be useful to repeat Arm 1 on a 




These findings are generally in line with other work testing the impact of EQ-5D-5L dimension order 
on the values produced for TTO and DCE which also did not find specific patterns based on a number 
of set dimension orders [12,13].  The previous work presented a small number of fixed orders 
between respondents.  This study adds to the past work by including two levels of randomisation 
where all EQ-5D-5L orders are possible either between (Arm 2) or within (Arm 3) respondents.  Arm 3 
was expected to generate more inconsistent data in comparison to Arms 1 and 2 given the cognitive 
burden of having to complete choice tasks where the order changed each time.  The poolability 
assessment shows that this was not the case, and the results support previous findings in this area 
[7,8]  
 
An issue for consideration is the minor coefficient disordering found across the arms. A similar level of 
disordering is common in DCE studies with and without duration.  For example disordering between 
anxiety/depression levels 4 (severe) and 5 (extreme) was found for Arm 1 in this study, and this was 
apparent in an earlier  DCETTO study valuing EQ-5D-5L in Australia [8], and it is worth noting that both 
used the ‘standard’ dimension order. In other DCETTO work comparing zero and non-zero prior design 
strategies Mulhern and colleagues [22] found different levels of disordering across the designs 
between self-care levels 1 (none) and 2 (slight), usual activities levels 2 (slight) and 3 (moderate) - a 
disordering also found in this study, and pain/discomfort levels 2 and 3.  This demonstrates that 
disordering is common in DCE studies, but there is no clear pattern.  There are a number of reasons 
why disordering may occur including the study design and choice set selection methods used, the 
format of the DCE task where respondents may not be clear about the overall ordering of the levels, 
and respondent perception of the level descriptors.  For example, in qualitative work and modelling 
studies, difficulty distinguishing ‘severe’ and ‘extreme’ has been reported [24,25] both semantically 
and in terms of severity, where a maximum trade-off is reached at severe as both levels are as bad as 
each other.  Disordering at the lower severity levels may be due to dominant attribute heuristics 
leading respondents to put less weight on trade-offs between lower severity levels of less important 
dimensions.  To deal with disordering it is possible to impose ordering, or test other models that may 
help to order the coefficients (for example including interactions).  However as this paper is a 
methodological comparison of dimension ordering, we have not done this as the level of disordering is 
a useful part of the comparative analysis. 
 
The standard order of EQ-5D health state dimension presentation has been used in a wide range of 
TTO [26] and DCE [5,9] valuation studies.  For EQ-5D the standard order was originally used as it 
was hypothesised to allow respondents to build up a picture of the health state starting with the 
functional dimensions (MO, SC and UA).  However in DCE, order effects might be important because 
of heuristics.  However the results of this study suggest that the models are similar irrespective of 
whether the study design employs the standard order, or uses randomisation, and there was no 
difference across the arms in terms of respondents reporting that the task was difficult overall.  
Therefore for DCETTO we do not find evidence to suggest that the inherent logic hypothesised in the 
standard order of the state is an important factor in the task completion process.  Future studies 
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should consider using the standard order, or imposing between subjects randomisation (i.e. arm 2), if 
there is concern about the residual possibility of bias which can be controlled for whilst presenting 
each respondent with only one dimension order as has been the standard in all previous DCETTO 
studies [6-9].  
 Using a dimenison order that makes the valuation process as easy as possible would appear 
important, however respondents in this study did not report that a particular level of randomisation 
was more difficult than the others when asked about imagining the states or task completion. DCE 
completed online may be prone to strategic completion and the use of heuristics, and the follow up 
questions used here are a way of eliciting useful data in this area.  This may not be the case with 
other valuation methods such as Time Trade Off where respondents typically consider a single 
holistic impairment profile in that case against full health.  
 
This study has a number of limitations.  We cannot fully understand respondent engagement with and 
concentration on the task beyond measuring the time taken, and their perception of the dimension 
orders presented, as the survey was online.  This, however, is an issue for all valuation work 
conducted using computer based methods.  The results of the follow up questions, and the small 
amount of disordered coefficients (i.e. one or three out of 20), suggests that respondents had a 
reasonable level of engagement. This is because disordering across the descriptive system and 
within each dimension would be expected if a large group of respondents answered at random.  Eye 
tracking methods could be utilised to further understand the process used to complete the tasks and 
the dimensions focused on by respondents, and this has been done elsewhere for DCE [27].  We also 
have not tested the impact of altering the position of the duration attribute as the focus of this study 
was the dimensions included in the EQ-5D, something which would be valuable future research.  In 
our analysis we were also unable to identify effects within a dimension when the ordering was 
changed (for example what is the impact on preferences for pain/discomfort when different 
dimensions appear in the first position in the order).  Regarding our model testing the impact of 
dimension order, we chose to apply an additive model in line with other work in this area [14], and did 
not include a multiplicative model which could be an equally valid way to test order effects. This is an 
area for further investigation.  We also did not allow for any modelling of preference heterogeneity due 
to the size of the sample.  However as the aim is to assess the impact of dimension order the study 
design and modelling carried out was sufficient to answer this question. 
 
Conclusion 
The impact of dimension order appears minimal which supports past valuation work in this area that 
has used the standard order.  The results suggest that the level of randomisation used in DCE health 
state valuation studies does not significantly impact valuations, and dimension order may not be 
important as other design issues in the completion of DCETTO studies.  Therefore it is reasonable to 
use the standard presentation of dimensions employed in the self-complete version.  
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Table 1: Demographics of the sample across each arm 
Demographic Arm 1 (N,%) Arm 2 (N,%) Arm 3 (N,%) Significance 
N 366 (34.1) 346 (32.3) 361 (33.6)  
Age group    0.414 
18-29 93 (25.4) 80 (23.1) 79 (21.8)  
30-44 95 (26.0) 105 (30.3) 86 (23.8)  
45-59 86 (23.5) 76 (22.0) 103 (28.5)  
60-74 61 (16.7) 60 (17.3) 67 (18.6)  
75+ 31 (8.5) 25 (7.2) 26 (7.2)  
Male 189 (51.6) 162 (46.8) 172 (47.6) 0.384 
Country of birth    0.437 
Australia 292 (79.8) 263 (76.0) 277 (76.7)  
Other 74 (20.2) 83 (24.0) 84 (23.3)  
Highest education level    0.656 
Primary 20 (5.5) 19 (5.5) 15 (4.2)  
Secondary 109 (29.7) 97 (28.0) 119 (55.1)  
Trade cert/diploma 120 (32.8) 117 (33.8) 111 (30.7)  
Bachelors 78 (21.3) 85 (24.6) 88 (24.3)  
Higher 39 (10.7) 28 (8.1) 28 (7.8)  
Currently studying 59 (16.1) 30 (8.7) 46 (12.7) 0.212 
Has child up to 16 32 (8.7) 26 (7.5) 24 (6.6) 0.565 
Self-rated health status    0.443 
Excellent 43 (11.7) 48 (13.9) 46 (12.7)  
Very good 141 (38.5) 114 (32.9) 130 (36.0)  
Good 118 (32.2) 103 (29.8) 102 (28.2)  
Fair 48 (13.1) 63 (18.2) 68 (18.8)  
Poor 16 (4.4) 18 (5.2) 15 (4.2)  
Chronic condition 150 (41.0) 146 (42.2) 150 (41.6) 0.948 
Condition reported     
Tiredness/fatigue 51 (14.0) 53 (15.3) 52 (14.4) 0.869 
High blood pressure 69 (18.9) 53 (15.3) 72 (19.9) 0.249 
Pain 70 (19.1) 76 (22.0) 80 (22.2) 0.533 
Heart disease 15 (4.1) 14 (4.0) 19 (5.3) 0.672 
Insomnia 29 (7.9) 37 (10.7) 38 (10.5) 0.369 
Osteoarthritis 46 (12.6) 35 (10.1) 50 (13.9) 0.306 
Anxiety/nerves 65 (17.8)  55 (15.9) 71 (19.7) 0.424 
Stroke 9 (2.5) 2 (0.6) 4 (1.1) 0.086 
Depression 68 (18.6) 62 (17.9) 61 (16.9) 0.837 
Cancer 9 (2.5) 7 (2.0) 10 (2.8) 0.811 
Diabetes 25 (6.8) 28 (8.1) 26 (7.2) 0.804 





Table 2: Unanchored and anchored DCE model coefficients 
 
Parameter Arm 1 Arm 2 Arm 3 
 Coef.a Sigb Disutilityc Coef. Sig Disutility Coef. Sig Disutility 
MO2 x Td -0.011 0.269 -0.050 -0.026 0.008 -0.122 -0.031 0.001 -0.153 
MO3 x T -0.026 0.006 -0.119 -0.035 <0.001 -0.164 -0.033 0.001 -0.163 
MO4 x T -0.087 <0.001 -0.397 -0.075 <0.001 -0.352 -0.072 <0.001 -0.355 
MO5 x T -0.103 <0.001 -0.470 -0.101 <0.001 -0.474 -0.106 <0.001 -0.522 
SC2 x T -0.032 0.001 -0.146 -0.025 0.012 -0.117 -0.012 0.211 -0.059 
SC3 x T -0.034 0.001 -0.155 -0.037 <0.001 -0.174 -0.036 <0.001 -0.178 
SC4 x T -0.074 <0.001 -0.338 -0.075 <0.001 -0.352 -0.077 <0.001 -0.379 
SC5 x T -0.095 <0.001 -0.434 -0.080 <0.001 -0.376 -0.102 <0.001 -0.502 
UA2 x T -0.021 0.019 -0.096 -0.017 0.059 -0.080 -0.004 0.633 -0.020 
UA3 x T -0.012 0.183 -0.055 -0.009 0.360 -0.042 0.004 0.657 0.020 
UA4 x T -0.050 <0.001 -0.228 -0.049 <0.001 -0.230 -0.028 0.003 -0.138 
UA5 x T -0.055 <0.001 -0.251 -0.045 <0.001 -0.212 -0.033 0.002 -0.163 
PD2 x T 0.004 0.703 0.018 -0.016 0.119 -0.075 -0.012 0.221 -0.059 
PD3 x T -0.014 0.140 -0.064 -0.039 <0.001 -0.183 -0.014 0.155 -0.069 
PD4 x T -0.051 <0.001 -0.233 -0.080 <0.001 -0.376 -0.067 <0.001 -0.315 
PD5 x T -0.071 <0.001 -0.324 -0.101 <0.001 -0.475 -0.093 <0.001 -0.458 
AD2 x T -0.020 0.039 -0.091 -0.016 0.112 -0.075 -0.009 0.378 -0.044 
AD3 x T -0.040 <0.001 -0.183 -0.027 0.012 -0.127 -0.024 0.019 -0.118 
AD4 x T -0.070 <0.001 -0.320 -0.075 <0.001 -0.352 -0.065 <0.001 -0.320 
AD5 x T -0.067 <0.001 -0.306 -0.055 <0.001 -0.258 -0.068 <0.001 -0.335 
T 0.219 <0.001  0.213 <0.001  0.203 <0.001  
Number of observations 3646   3458   3603   
Log Likelihood -2226   -2153   -2203   
Range (11111 to 55555)   1 to -0.785   1 to -0.795   1 to -0.980 
Coefficient magnitude order 
(largest level 5 value first) 
MO – SC – PD – AD – UA  PD – MO – SC – AD – UA MO – SC – PD – AD - UA 
a Coefficient for the decrement of each level of each health state dimension from the baseline level 1 (no problems) 
 b Significance of each coefficient value in comparison to the baseline level 1
  
c The anchored coefficient for each level of each dimension used to calculate utility values for each health state 
d Each parameter is listed as an interaction of the health state dimension level (MO2, MO3, etc) and duration (T). MO: 
mobility; SC: self-care; UA: usual activities; PD: pain/discomfort; AD: anxiety/depression 




Table 3: Unanchored and anchored pooled DCE model coefficients for Swait and Louviere 
(1993) test 
 
Parameter Unrestricted pooled model Restricted pooled model 
 Coef.a Sigb Disutilityc Coef. Sig Disutility 
MO2 x Td -0.023 <0.001 -0.110 -0.023 <0.001 -0.107 
MO3 x T -0.031 <0.001 -0.148 -0.032 <0.001 -0.150 
MO4 x T -0.079 <0.001 -0.376 -0.080 <0.001 -0.374 
MO5 x T -0.103 <0.001 -0.490 -0.105 <0.001 -0.491 
SC2 x T -0.023 <0.001 -0.110 -0.023 <0.001 -0.107 
SC3 x T -0.036 <0.001 -0.171 -0.036 <0.001 -0.168 
SC4 x T -0.075 <0.001 -0.357 -0.077 <0.001 -0.360 
SC5 x T -0.092 <0.001 -0.438 -0.094 <0.001 -0.439 
UA2 x T -0.014 0.008 -0.067 -0.014 0.008 -0.065 
UA3 x T -0.005 0.356 -0.024 -0.005 0.359 -0.023 
UA4 x T -0.042 <0.001 -0.200 -0.043 <0.001 -0.201 
UA5 x T -0.043 <0.001 -0.205 -0.044 <0.001 -0.206 
PD2 x T -0.008 0.185 -0.038 -0.008 0.194 -0.037 
PD3 x T -0.023 <0.001 -0.110 -0.023 <0.001 -0.107 
PD4 x T -0.065 <0.001 -0.310 -0.066 <0.001 -0.308 
PD5 x T -0.088 <0.001 -0.419 -0.089 <0.001 -0.416 
AD2 x T -0.015 0.007 -0.071 -0.016 0.007 -0.075 
AD3 x T -0.031 <0.001 -0.148 -0.031 <0.001 -0.145 
AD4 x T -0.070 <0.001 -0.333 -0.072 <0.001 -0.336 
AD5 x T -0.064 <0.001 -0.305 -0.065 <0.001 -0.304 
T 0.210 <0.001  0.214 <0.001  
Number of observations 10707   10707   
Log Likelihood -6604   -6603   
Range (11111 to 55555)   1 to -0.857   1 to -0.856 
Coefficient magnitude order 
(largest level 5 value first) 
MO-SC-PD-AD-UA MO-SC-PD-AD-UA 
a Coefficient for the decrement of each level of each health state dimension from the baseline level 1 (no problems) 
b Significance of each coefficient value in comparison to the baseline level 1 
c The anchored coefficient for each level of each dimension used to calculate utility values for each health state 
d Each parameter is listed as an interaction of the health state dimension level (MO2, MO3, etc) and duration (T). MO: 
mobility; SC: self-care; UA: usual activities; PD: pain/discomfort; AD: anxiety/depression 




Table 4: Modelling order effects 
Parameter Coefficienta Significanceb 
MO2 x Tc -0.032 0.001 
MO3 x T -0.039 <0.001 
MO4 x T -0.077 <0.001 
MO5 x T -0.109 <0.001 
SC2 x T -0.022 0.019 
SC3 x T -0.040 <0.001 
SC4 x T -0.078 <0.001 
SC5 x T -0.096 <0.001 
UA2 x T -0.015 0.115 
UA3 x T -0.006 0.529 
UA4 x T -0.042 <0.001 
UA5 x T -0.042 <0.001 
PD2 x T -0.017 0.065 
PD3 x T -0.033 <0.001 
PD4 x T -0.077 <0.001 
PD5 x T -0.104 <0.001 
AD2 x T -0.016 0.090 
AD3 x T -0.030 0.002 
AD4 x T -0.073 <0.001 
AD5 x T -0.068 <0.001 
T 0.211 <0.001 
2nd position x level 2 x Td -0.006 0.516 
2nd position x level 3 x T -0.005 0.585 
2nd position x level 4 x T -0.003 0.752 
2nd position x level 5 x T -0.007 0.484 
3rd position x level 2 x T 0.013 0.174 
3rd position x level 3 x T 0.015 0.129 
3rd position x level 4 x T 0.023 0.016 
3rd position x level 5 x T 0.019 0.067 
4th position x level 2 x T 0.010 0.282 
4th position x level 3 x T 0.012 0.196 
4th position x level 4 x T 0.003 0.739 
4th position x level 5 x T 0.007 0.525 
5th position x level 2 x T -0.001 0.880 
5th position x level 3 x T -0.001 0.917 
5th position x level 4 x T -0.011 0.239 
5th position x level 5 x T 0.004 0.675 
a Coefficient for the decrement of each level of each health state dimension from the baseline level 1 (no problems) 
b Significance of each coefficient value in comparison to the baseline level 1 
c Each parameter is listed as an interaction of the health state dimension level (MO2, MO3, etc) and duration (T). MO: 
mobility; SC: self-care; UA: usual activities; PD: pain/discomfort; AD: anxiety/depression 
d Each parameter is listed as an interaction of the position the dimension appears in the choice set, and the health state 
dimension level and duration 




Table 5: Summary of follow up questions about task completion 
 Arm 1 Arm 2 Arm 3 Siga 
Answer focusing on only part of choice set?    0.122 
Yes 200 (54.6) 213 (61.6) 219 (60.7)  
No 166 (45.4) 133 (38.4) 142 (39.3)  
Which part?    0.649 
Mobility 44 (17.4) 33 (13.0) 38 (14.7)  
Self-care 39 (15.4) 53 (20.9) 42 (16.3)  
Usual activities 26 (10.3) 26 (10.2) 21 (8.1)  
Pain/discomfort 67 (26.5) 67 (26.4) 74 (28.7)  
Anxiety/depression 30 (11.9) 34 (13.4) 42 (16.3)  
Duration 47 (18.6) 41 (16.1) 41 (15.9)  
Strategy used to answer the question     0.776 
No strategy 85 (23.2) 76 (22.0) 90 (24.9)  
Focus on few aspects 59 (16.1) 48 (13.9) 57 (15.8)  
Focus on most aspects 102 (27.9) 91 (26.3) 95 (26.3)  
Focus on all aspects 120 (32.8) 131 (37.9) 119 (33.0)  
a Significance across arms using one way ANOVA 
 
